购物车
- 全部删除
- 您的购物车当前为空
PHPS1 是 Shp2的选择性抑制剂,对 Shp2,Shp2-R362K,Shp1,PTP1B 和 PTP1B-Q 的 Ki 分别为 0.73,5.8,10.7,5.8 和 0.47 μM。
PHPS1 是 Shp2的选择性抑制剂,对 Shp2,Shp2-R362K,Shp1,PTP1B 和 PTP1B-Q 的 Ki 分别为 0.73,5.8,10.7,5.8 和 0.47 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 227 | 现货 | |
2 mg | ¥ 325 | 现货 | |
5 mg | ¥ 535 | 现货 | |
10 mg | ¥ 828 | 现货 | |
25 mg | ¥ 1,630 | 现货 | |
50 mg | ¥ 2,310 | 现货 | |
100 mg | ¥ 3,230 | 现货 | |
200 mg | ¥ 4,480 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 636 | 现货 |
产品描述 | PHPS1 is an inhibitor of Shp2. PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-associated Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines. |
靶点活性 | PTP1B Q:0.47 μM(Ki), Shp2 (R362K):5.8 μM(Ki;Shp2-R362K), PTP1B:5.8 μM(Ki), SHP1:10.7 μM(Ki), SHP2:0.73 μM(Ki) |
体外活性 | PHPS1 (30 μM; 6 days) inhibits proliferation of human tumor cells[1]. PHPS1 (5-20 μM; 5-360 minutes) inhibits Erk1/2 but not Akt and Stat3 phosphorylation in a dose-dependent manner[1]. |
体内活性 | PHPS1 (3 mg/kg; i.p. injection; every day during the last week on the high-fat diet) renders Ldlr-/- mice less susceptible to atherosclerosis development[2]. |
别名 | PHPS-1, PHPS 1 |
分子量 | 465.44 |
分子式 | C21H15N5O6S |
CAS No. | 314291-83-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 16.25 mg/ml (34.91 mM) | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.